Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for TCMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 223.84M
March 31, 2026 217.87M
December 31, 2025 218.90M
September 30, 2025 204.95M
June 30, 2025 194.93M
March 31, 2025 205.63M
December 31, 2024 216.60M
September 30, 2024 207.90M
June 30, 2024 200.68M
March 31, 2024 193.47M
December 31, 2023 193.64M
September 30, 2023 182.83M
June 30, 2023 158.76M
March 31, 2023 156.16M
December 31, 2022 121.40M
September 30, 2022 114.40M
June 30, 2022 114.12M
March 31, 2022 114.98M
December 31, 2021 128.23M
September 30, 2021 132.11M
June 30, 2021 132.72M
March 31, 2021 125.12M
December 31, 2020 124.75M
September 30, 2020 109.12M
Date Value
June 30, 2020 103.38M
March 31, 2020 113.04M
December 31, 2019 112.60M
September 30, 2019 103.97M
June 30, 2019 99.01M
March 31, 2019 92.00M
December 31, 2018 89.27M
September 30, 2018 83.42M
June 30, 2018 78.77M
March 31, 2018 73.16M
December 31, 2017 72.79M
September 30, 2017 68.47M
June 30, 2017 66.19M
March 31, 2017 59.17M
December 31, 2016 59.64M
September 30, 2016 56.08M
June 30, 2016 27.63M
March 31, 2016 26.50M
December 31, 2015 27.28M
September 30, 2015 25.89M
June 30, 2015 24.61M
March 31, 2015
December 31, 2014 24.66M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Treace Medical Concepts, Inc. 67.74M
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M

Shareholders Equity (Quarterly) Related Metrics